Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial.

Pacey, Simon; Ratain, Mark J; Flaherty, Keith T; Kaye, Stanley B; Cupit, Lisa; Rowinsky, Eric K; Xia, Chenghua; O'Dwyer, Peter J; Judson, I R

Pacey, Simon; Ratain, Mark J; Flaherty, Keith T; Kaye, Stanley B; Cupit, Lisa; Rowinsky, Eric K; Xia, Chenghua; O'Dwyer, Peter J; Judson, I R.

Affiliation

Pacey S; The Royal Marsden Hospital, Downs Rd, Sutton, Surrey, SM2 5PT, UK.

Invest New Drugs ; 29(3): 481-8, 2011 Jun.

Article in En | MEDLINE | ID: mdl-20016927

Subject(s)

Benzenesulfonates/therapeutic use; Pyridines/therapeutic use; Sarcoma/drug therapy; Soft Tissue Neoplasms/drug therapy; Adult; Aged; Antineoplastic Agents/adverse effects; Antineoplastic Agents/therapeutic use; Benzenesulfonates/adverse effects; Demography; Female; Humans; Male; Middle Aged; Neoplasm Staging; Niacinamide/analogs & derivatives; Phenylurea Compounds; Pyridines/adverse effects; Sarcoma/diagnostic imaging; Soft Tissue Neoplasms/diagnostic imaging; Sorafenib; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Sarcoma / Soft Tissue Neoplasms / Benzenesulfonates Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2011 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google